Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-25-000011

Options or other derivatives

  • CEO & President acquired 3,634,868 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Adcock Richard · CEO & President

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-10 Grant or award : show line 1 in the form Restricted Stock Units +822,368 822,368 D
2025-02-10 Grant or award : show line 2 in the form Stock Option (right to buy) +2,812,500 2,812,500 D
Loading xslF345X05/wk-form4_1739409389.xml…